CS logo
small CS logo
Illinois CancerCare - Havana

Havana, Illinois, United States
Cancer treatment center in Peoria, Illinois
8940 Wood Sage Rd, Peoria, IL 61615

About Illinois CancerCare - Havana


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
42
Alliance for Clinical Trials in Oncology
39
Hoffmann-La Roche
17
SWOG Cancer Research Network
9
Celgene
6
Bristol-Myers Squibb
5
NSABP Foundation Inc
5
University of Chicago
5
ECOG-ACRIN Cancer Research Group
4
Genentech, Inc.
4
Janssen Research & Development, LLC
3
Total Rows: 40

Clinical Trials at Illinois CancerCare - Havana


During the past decade, Illinois CancerCare - Havana conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 106 clinical trials were completed, i.e. on average, 258.5% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 25 clinical trials were completed. i.e. 192.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years339944775566334410101212303012121717999944Started TrialsCompleted Trails20152016201720182019202020212022010203040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer
2006-12-01
Active, not recruiting
348
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
1984-06-01
Active, not recruiting
9,000
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer
2003-04-18
2011-04-21
Completed
1,886
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
2003-11-01
2027-01-01
Active, not recruiting
3,294
Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer
2004-09-01
2013-05-01
Completed
52
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
2005-03-01
2018-08-01
Completed
4,216
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610

Rows per page:

1–100 of 178

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Illinois CancerCare - Havana" #1 sponsor was "National Cancer Institute (NCI)" with 42 trials, followed by "Alliance for Clinical Trials in Oncology" with 39 trials sponsored, "Hoffmann-La Roche" with 17 trials sponsored, "SWOG Cancer Research Network" with 9 trials sponsored and "Celgene" with 9 trials sponsored. Other sponsors include 60 different institutions and companies that sponsored additional 40 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare - Havana" #1 collaborator was "National Cancer Institute (NCI)" with 63 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator and "NRG Oncology" with 6 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 32 trials.
Created with Highcharts 11.1.0Top Leading SponsorsNational CancerInstitute (NCI): 42National CancerInstitute (NCI): 42Alliance for ClinicalTrials in Oncology: 39Alliance for ClinicalTrials in Oncology: 39Hoffmann-La Roche: 17Hoffmann-La Roche: 17SWOG Cancer ResearchNetwork: 9SWOG Cancer ResearchNetwork: 9Celgene: 6Celgene: 6Bristol-Myers Squibb: 5Bristol-Myers Squibb: 5NSABP Foundation Inc: 5NSABP Foundation Inc: 5University of Chicago: 5University of Chicago: 5ECOG-ACRIN CancerResearch Group: 4ECOG-ACRIN CancerResearch Group: 4Genentech, Inc.: 4Genentech, Inc.: 4

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 63National CancerInstitute (NCI): 63SWOG Cancer ResearchNetwork: 7SWOG Cancer ResearchNetwork: 7Cancer and LeukemiaGroup B: 6Cancer and LeukemiaGroup B: 6NCIC Clinical Trials Group: 6NCIC Clinical Trials Group: 6NRG Oncology: 6NRG Oncology: 6North Central CancerTreatment Group: 4North Central CancerTreatment Group: 4Eastern CooperativeOncology Group: 3Eastern CooperativeOncology Group: 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Genentech, Inc.: 2Genentech, Inc.: 2Mayo Clinic: 2Mayo Clinic: 2

Clinical Trials Conditions at Illinois CancerCare - Havana


According to Clinical.Site data, the most researched conditions in "Illinois CancerCare - Havana" are "Breast Cancer" (18 trials), "Colorectal Cancer" (8 trials), "Lung Cancer" (8 trials), "Lymphoma" (7 trials) and "Leukemia" (5 trials). Many other conditions were trialed in "Illinois CancerCare - Havana" in a lesser frequency.

Clinical Trials Intervention Types at Illinois CancerCare - Havana


Most popular intervention types in "Illinois CancerCare - Havana" are "Drug" (151 trials), "Other" (65 trials), "Biological" (49 trials), "Radiation" (14 trials) and "Procedure" (6 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (32 trials), "Carboplatin" (19 trials), "Bevacizumab" (18 trials), "Paclitaxel" (17 trials) and "placebo" (16 trials). Other intervention names were less common.

Clinical Trials Genders at Illinois CancerCare - Havana


The vast majority of trials in "Illinois CancerCare - Havana" are 145 trials for "All" genders, 25 trials for "Female" genders and 8 trials for "Male" genders.

Clinical Trials Status at Illinois CancerCare - Havana


Currently, there are NaN active trials in "Illinois CancerCare - Havana". undefined are not yet recruiting, 16 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 86 completed trials in Illinois CancerCare - Havana, undefined suspended trials, and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Illinois CancerCare - Havana, 14 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 79Phase 3: 79Phase 2: 74Phase 2: 74Phase 1: 14Phase 1: 14Not Applicable: 3Not Applicable: 3Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 86Completed: 86Active, not recruiting: 52Active, not recruiting: 52Terminated: 19Terminated: 19Recruiting: 16Recruiting: 16Unknown status: 2Unknown status: 2Approved for marketing: 1Approved for marketing: 1Available: 1Available: 1No longer available: 1No longer available: 1

Departments of Illinois CancerCare - Havana


Illinois CancerCare - Havana has several departments that took part in Clinical trials: "Illinois CancerCare-Dixon" - 125 trials, "Oncology Hematology Associates of Central Illinois, PC - Ottawa" - 108 trials, "Illinois CancerCare - Washington" - 106 trials, "Illinois CancerCare-Pekin" - 453 trials, "Illinois CancerCare-Peoria" - 389 trials, "Illinois CancerCare-Galesburg" - 365 trials, "Illinois CancerCare-Bloomington" - 356 trials, "Illinois CancerCare-Peru" - 354 trials, "Illinois CancerCare-Canton" - 351 trials, "Illinois CancerCare-Macomb" - 350 trials, "Illinois CancerCare-Eureka" - 348 trials, "Illinois CancerCare-Princeton" - 347 trials, "Illinois CancerCare-Kewanee Clinic" - 345 trials, "Illinois CancerCare-Carthage" - 343 trials, "Illinois CancerCare-Ottawa Clinic" - 324 trials